SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001485003-17-000004
Filing Date
2017-02-16
Accepted
2017-02-16 17:09:48
Documents
1
Period of Report
2017-02-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_148728297397095.html 4  
1 FORM 4 wf-form4_148728297397095.xml 4 3362
  Complete submission text file 0001485003-17-000004.txt   4771
Mailing Address C/O ELEVEN BIOTHERAPEUTICS, INC. 215 FIRST STREET, SUITE 400 CAMBRIDGE MA 02142
Business Address
MCCABE JOHN J (Reporting) CIK: 0001205535 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36296 | Film No.: 17618721

Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Issuer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences